Alcon, Inc. (NYSE:ACL) has filed its Form 20-F annual report of foreign private issuer with the U.S. Securities and Exchange Commission (SEC). An electronic version of this annual filing is available for review in the Investors and Media section of the company’s web site or in the SEC’s EDGAR database at www.sec.gov.

Investors may obtain a printed copy of Alcon’s audited financial statements free of charge by contacting Alcon Investor Relations either by phone, e-mail or in writing at the address below.

Alcon Investor Relations6201 South Freeway, MC TA7-5Fort Worth, TX 76134Phone: 1-800-400-8599 investor.relations@alconlabs.com www.alcon.com

About Alcon

Alcon, Inc. is the world’s leading eye care company, with sales of approximately $7.2 billion in 2010. Alcon, which has been dedicated to the ophthalmic industry for 65 years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contacts lens solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon operates in 75 countries and sells products in 180 markets. For more information on Alcon, Inc., visit the Company’s web site at www.alcon.com.

Copyright Business Wire 2010

If you liked this article you might like

Has IBM Finally Gotten Cheap?

Novartis Profit Falls 4%, Sales Rise 16%

Novartis Profit Falls 4%, Sales Rise 16%

First Solar, Dynegy: Premarket Trading

First Solar, Dynegy: Premarket Trading

Novartis Buys Rest of Alcon Stake for $12.9B

Novartis Buys Rest of Alcon Stake for $12.9B

10 Top Hedge Fund Buys Show M&A Tilt